Fresenius Medical Care (NYSE: FMS) — Perfil da empresa, notícias e dados financeiros
Fresenius Medical Care focuses on dialysis products and services, enhancing patient care across various countries for kidney failure.
Fresenius Medical Care
Fresenius Medical Care is a healthcare company specializing in dialysis products and clinical services for individuals affected by chronic kidney disease and end-stage renal disease. The organization provides outpatient hemodialysis and peritoneal dialysis treatments through a global network of dedicated medical centers. In addition to direct patient care, the enterprise manufactures and distributes kidney dialysis machines, dialyzers, peritoneal dialysis fluids, and specialized acute blood purification systems. Operating globally, the company supports nephrology professionals, hospitals, and home care patients across North America, Europe, Asia-Pacific, Latin America, and other international jurisdictions.
Resumo
Operações
Produtos e/ou serviços de Fresenius Medical Care
- Care Enablement: Development, manufacturing, and distribution of medical equipment and supplies for renal care, including advanced hemodialysis machines, dialyzers, bloodlines, peritoneal dialysis equipment, and specialized water treatment systems for clinical and home environments.
- Care Delivery Services: Provision of comprehensive outpatient dialysis care, in-center hemodialysis treatments, home dialysis training, and clinical management services for hundreds of thousands of patients suffering from chronic kidney failure across international healthcare clinic networks.
- Critical Care and Acute Therapies: Provision of continuous renal replacement therapy hardware, acute blood purification systems, therapeutic apheresis platforms, and extracorporeal organ support equipment for intensive care patients experiencing acute kidney injury or systemic illness.
- Home Dialysis Solutions: Provision of portable home hemodialysis machines, automated peritoneal dialysis cyclers, specialized dialysis fluids, and virtual training applications designed to facilitate home-based renal replacement therapy for chronic kidney failure patients.
- Digital Health Solutions: Provision of integrated nephrology software systems, connected health applications, therapy data management platforms, and remote patient monitoring software that streamline clinical workflows and facilitate data exchange between patients and care teams.
- Renal Pharmaceuticals and Value-Based Care: Supply of specialized renal pharmaceuticals, laboratory diagnostic testing, and value-based healthcare management models designed to coordinate whole-person care for kidney disease patients while optimizing clinical outcomes and healthcare costs.
equipe executiva do Fresenius Medical Care
- Martin FischerCFO & Member of the Management Board
- Jorg HaringMember of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director
- Joseph E. Turk Jr.CEO of Care Enablement & Member of Management Board
- Charles Hugh-JonesGlobal Chief Medical Officer & Member of Management Board
- Cassie McLeanCEO of Care Delivery & Member of Management Board
- Dominik HegerExecutive VP and Head of Investor Relations, Strategic Development & Communications
- Joachim WeithSenior Vice President of Corporate Communications & Governmental Affairs
- Gail-Suzanne BrownSenior Vice President of Research & Development
- Glenn SlaterSenior Vice President of Manufacturing and Supply Chain Operations
- Wolfgang KummerleSenior Vice President - Quality Management International
Últimas notícias sobre a Fresenius Medical Care
Comunicados recentes
O que a Fresenius Medical Care (FMS) comunicou ao mercado, do mais recente para o mais antigo.
- NEWS_HALT halt | FMSFato relevante
Histórico de dividendos
Dividendos por ação pagos pela Fresenius Medical Care , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $0.6117 |
| FY2025 | — | — | — | $0.8150 |
| FY2024 | — | — | — | $0.6340 |
| FY2023 | — | — | — | $0.6180 |
| FY2022 | — | — | — | $0.7090 |
Principais indicadores financeiros
Resultados divulgados pela Fresenius Medical Care , em EUR.
- Cap. de mercado
- 12 bi
- Receita (TTM)
- 19,4 bi
- P/L
- 11.6
- LPA (diluído, TTM)
- 1.9
- Dividend yield
- 3.9%
- Margem de lucro
- 4.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 19,6 bi | 1,8 bi | 978,4 mi | |
| 19,3 bi | 1,5 bi | 537,9 mi | |
| 19,5 bi | 1,4 bi | 499 mi | |
| 19,4 bi | 1,5 bi | 673,4 mi |